Serometrix ^Companies

Serometrix, LLC, a biotech drug discovery company, provides targeted lead stage molecules for preclinical drug development. The company offers Peptimer, a discovery platform, which identifies touch points critical to specific protein-protein interactions of interest. It provides its platform for oncology, cardiovascular, metabolic, CNS, and infectious diseases. The company was founded in 2001 and is based in Pittsford, New York.